Chih-Hao Lu

Title: Chih-Hao Lu: Innovator in Immunogenic Research

Introduction

Chih-Hao Lu is a prominent inventor based in Miaoli County, Taiwan. He has made significant contributions to the field of immunology through his innovative research and patent developments. His work focuses on enhancing immune responses, which has important implications for vaccine development and therapeutic applications.

Latest Patents

Chih-Hao Lu holds a patent for a CpG-oligodeoxynucleotide, immunogenic composition including the same, and method of inducing immune response by the same. This patent describes a CpG-oligodeoxynucleotide (CpG-ODN) designed to induce a TLR9 activated immune response, a TLR21 activated immune response, or a combination thereof in a host. The CpG-ODN includes one or more copies of the sequences of GTCGTT, GTT, and TTTT, with specific arrangements that enhance its effectiveness. This innovative approach provides a new avenue for inducing immune responses, which is crucial for advancing immunotherapy.

Career Highlights

Chih-Hao Lu is affiliated with the National Health Research Institutes, where he conducts his research. His work has led to advancements in understanding immune mechanisms and developing new immunogenic compositions. His dedication to research and innovation has positioned him as a key figure in the field of immunology.

Collaborations

Chih-Hao Lu collaborates with esteemed colleagues such as Tsung-Hsien Chuang and Da-Wei Yeh. These collaborations enhance the research output and foster a multidisciplinary approach to tackling complex immunological challenges.

Conclusion

Chih-Hao Lu's contributions to immunogenic research through his patent and collaborations highlight his role as an innovator in the field. His work continues to pave the way for advancements in immune response therapies and vaccine development.